Research background · Updated November 1, 2026
Cerebrolysin Research: Publications, Study Types and Background
Short answer
Cerebrolysin. As of November 1, 2026, PubMed indexes 639 records matching Cerebrolysin, the earliest from 1973; 171 were published in 2021–2025 and 96 are reviews. ClinicalTrials.gov lists 43 registered studies matching the compound.
- PubMed records
- 639
- Earliest record
- 1973
- Published 2021–2025
- 171
- Reviews
- 96
- Animal-only studies
- 203
- Registered studies
- 43
Publications per year, 2006–2025
330 records in 2016–2025 against 170 in 2006–2015; the busiest year was 2025, with 47.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 14 |
| 2007 | 11 |
| 2008 | 12 |
| 2009 | 11 |
| 2010 | 18 |
| 2011 | 19 |
| 2012 | 16 |
| 2013 | 22 |
| 2014 | 23 |
| 2015 | 24 |
| 2016 | 30 |
| 2017 | 31 |
| 2018 | 24 |
| 2019 | 36 |
| 2020 | 30 |
| 2021 | 32 |
| 2022 | 22 |
| 2023 | 43 |
| 2024 | 35 |
| 2025 | 47 |
Study types
| All PubMed records | 639 |
|---|---|
| Reviews | 9615% |
| Animal studies (no human subjects indexed) | 20332% |
| Indexed as clinical trials | 8914% |
| Registered on ClinicalTrials.gov | 43 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent Cerebrolysin papers report, in their own authors’ terms. Each line links the paper it came from.
Subarachnoid haemorrhage
This review and meta-analysis of clinical trials in subarachnoid haemorrhage reports data suggesting a positive effect of Cerebrolysin on mortality, and states that larger randomized trials are needed.
ReviewKojder K 2023Journal of clinical medicinePMID 37892776
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 400 of the 639 records. They describe what the literature is about, not what Cerebrolysin does.
- Amino Acids241 papers
- Neuroprotective Agents163 papers
- Stroke59 papers
- Nootropic Agents52 papers
- Brain Ischemia41 papers
- Alzheimer Disease41 papers
- Brain26 papers
- Brain Injuries22 papers
Key papers
Earliest indexed record
Zhovnir IK (1973). Vrachebnoe delo.
PMID 4786906Most-cited paper · 151 citations
Zhang C (2010). Journal of neuroscience research.
PMID 20857512Most-cited #2 · 119 citations
Zhang L (2013). Stroke.
PMID 23696546Most-cited #3 · 107 citations
Muresanu DF (2016). Stroke.
PMID 26564102
Citation counts from NIH iCite, among the 400 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| Identity data | On request |
|---|
Identity data from PubChem, retrieved November 1, 2026, on the Cerebrolysin page.
How these numbers were counted
- PubMed search, run November 1, 2026:
cerebrolysin[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
cerebrolysinre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Cerebrolysin outside a laboratory.
Wholesale supply
Cerebrolysin, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Cerebrolysin research questions
How much research has been published on Cerebrolysin?
PubMed indexes 639 records matching Cerebrolysin (searched November 1, 2026), including 96 reviews and 89 records indexed as clinical trials. 171 were published in the five years 2021–2025.
When was Cerebrolysin first described in the literature?
The earliest PubMed record matching Cerebrolysin is from 1973 (Zhovnir IK, Vrachebnoe delo, PMID 4786906).
What topics does the Cerebrolysin literature cover?
The subject headings PubMed indexers most often marked as a main topic of Cerebrolysin papers are Amino Acids, Neuroprotective Agents, Stroke, Nootropic Agents. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Cerebrolysin sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Cerebrolysin wholesale for research?
We source Cerebrolysin to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.